HCIT & Life Sciences

The intersection of trends in HCIT and Life Sciences technology is a core thesis that we continue to applaud. These intersecting technologies not only allow providers to understand patients better, but can also deliver customized experiences in addition to elevating health care engagement.

HCIT & Life Sciences

 Transactions

Microfluidics is very pleased with their decision to work with Tim Harned and the entire AGC team regarding its strategic evaluation and sale to IDEX. AGC served as a trusted advisor to management and the Board of Directors through a complicated process and worked diligently to manage multiple constituents to ensure success. This is a great outcome for Microfluidics and its stockholders, employees and customers, and we owe a lot of that to the unwavering efforts of our team at AGC. I would recommend Tim Harned and AGC to any company and look forward to working with them again.

Michael C. Ferrara, CEO of Microfluidics

AGC acted as sole financial advisor to Microfluidics in February, 2011

Get in touch and experience the AGC difference